A Case Study from the Chemistry Core of the Pittsburgh Molecular Library Screening Center: The Polo-like Kinase Polo-Box Domain (Plk1- PBD)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|9|13|1194-1205

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.9, Iss.13, 2009-09, pp. : 1194-1205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 2014-2025

Bentham Science Publishers

Access to resources Recommend Favorite

Real-time Fluorescent Quantitative Polymerase Chain Reaction Study of Polo-like Kinase-1 in Pterygia

By Lu H   Lou DH   Zhu LL  

The Journal of International Medical Research, Vol. 37, Iss. 6, 2009-11 ,pp. : 1851-1858

Field House Publishing

Access to resources Recommend Favorite

Polo-Like Kinase 1 as a Potential Therapeutic Target for Osteosarcoma

By  

Current Pharmaceutical Design, Vol. 21, Iss. 10, 2015-03 ,pp. : 1347-1350

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Discovery of Polo-like Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 2, 2005-04 ,pp. : 181-197

Bentham Science Publishers

Access to resources Recommend Favorite

Polo-like kinases in AML

By Berg Tobias   Bug Gesine   Ottmann Oliver G   Strebhardt Klaus  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 8, 2012-08 ,pp. : 1069-1074

Informa Healthcare

Access to resources Recommend Favorite